Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
Latest Information Update: 07 Jan 2025
At a glance
- Drugs Daratumumab (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
Most Recent Events
- 03 Jan 2025 Status changed from recruiting to completed.
- 02 May 2023 New trial record